In line with this, mutations in APP or the APP-cleaving enzymes presenilin 1 and 2 are implicated in early-onset familial AD cases, whereas the numerous risk factors identified for non-familial AD cases characterize late onset disease. This evidence concerns the gene PSEN1 and Alzheimer disease.